# Monopar Therapeutics (MNPR) — Analyst Forecast

MNPR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mnpr/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 11, 2026 | Barclays | Maintained | Overweight | $145.00 |
| Aug 13, 2026 | Cantor Fitzgerald | Downgraded | Overweight → Neutral | $119.00 |
| Aug 13, 2026 | Barclays | Maintained | Overweight | $128.00 |
| Aug 12, 2026 | BTIG | Maintained | Buy | $133.00 |
| Jul 22, 2026 | HC Wainwright & Co. | Maintained | Buy | $125.00 |
| Jun 30, 2026 | BTIG | Maintained | Buy | $117.00 |
| Jun 29, 2026 | HC Wainwright & Co. | Maintained | Buy | $105.00 |
| Mar 30, 2026 | Chardan Capital | Maintained | Buy | $100.00 |
| Feb 23, 2026 | BTIG | Maintained | Buy | $104.00 |
| Feb 2, 2026 | BTIG | Maintained | Buy | $104.00 |
| Jan 29, 2026 | Chardan Capital | Maintained | Buy | $100.00 |
| Jan 14, 2026 | BTIG | Maintained | Buy | $104.00 |
| Jan 9, 2026 | Morgan Stanley | Initiated Coverage | Overweight | $115.00 |
| Nov 14, 2025 | Raymond James | Downgraded | Strong Buy → Outperform | $123.00 |
| Nov 13, 2025 | Chardan Capital | Maintained | Buy | $100.00 |
| Nov 10, 2025 | Leerink Partners | Initiated Coverage | Outperform | $115.00 |
| Nov 9, 2025 | Chardan Capital | Maintained | Buy | $100.00 |
| Oct 13, 2025 | Barclays | Initiated Coverage | Overweight | $125.00 |
| Oct 6, 2025 | Raymond James | Maintained | Strong Buy | $142.00 |
| Oct 2, 2025 | Oppenheimer | Maintained | Outperform | $115.00 |

## Frequently Asked Questions

### What is the latest analyst rating on MNPR?

On Sep 11, 2026, Barclays maintained Monopar Therapeutics at Overweight with a price target of $145.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).